Thyroid disruption by perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA).

Coperchini, F; Awwad, O; Rotondi, M; Santini, F; Imbriani, M; Chiovato, L

Coperchini, F; Awwad, O; Rotondi, M; Santini, F; Imbriani, M; Chiovato, L.

Afiliação

Coperchini F; Unit of Internal Medicine and Endocrinology, Laboratory for Endocrine Disruptors Fondazione, Salvatore Maugeri I.R.C.C.S., Chair of Endocrinology, University of Pavia, Via Maugeri 10, 27100, Pavia, Italy.
Awwad O; Department of Biopharmaceutics and Clinical Pharmacy, The University of Jordan, Amman, Jordan.
Rotondi M; Unit of Internal Medicine and Endocrinology, Laboratory for Endocrine Disruptors Fondazione, Salvatore Maugeri I.R.C.C.S., Chair of Endocrinology, University of Pavia, Via Maugeri 10, 27100, Pavia, Italy.
Santini F; Endocrinology Unit 1, Department of Clinical and Experimental Medicine, University Hospital of Pisa, Pisa, Italy.
Imbriani M; Department of Public Health, Experimental and Forensic Medicine, University of Pavia, Pavia, Italy.
Chiovato L; Unit of Internal Medicine and Endocrinology, Laboratory for Endocrine Disruptors Fondazione, Salvatore Maugeri I.R.C.C.S., Chair of Endocrinology, University of Pavia, Via Maugeri 10, 27100, Pavia, Italy. luca.chiovato@fsm.it.

J Endocrinol Invest ; 40(2): 105-121, 2017 Feb.

Article em En | MEDLINE | ID: mdl-27837466

Assuntos

Ácidos Alcanossulfônicos/metabolismo; Caprilatos/metabolismo; Fluorocarbonos/metabolismo; Doenças da Glândula Tireoide/epidemiologia; Doenças da Glândula Tireoide/metabolismo; Feminino; Humanos; Gravidez

Palavras-chave

PFOA; PFOS; Thyroid

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças da Glândula Tireoide / Caprilatos / Ácidos Alcanossulfônicos / Fluorocarbonos Tipo de estudo: Prognostic_studies Limite: Female / Humans / Pregnancy Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google